These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34226290)

  • 21. Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.
    Tran KT; McMenamin ÚC; Hicks B; Murchie P; Thrift AP; Coleman HG; Iversen L; Johnston BT; Lee AJ; Cardwell CR
    Aliment Pharmacol Ther; 2018 Jul; 48(1):55-64. PubMed ID: 29741272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
    Liu P; McMenamin ÚC; Johnston BT; Murchie P; Iversen L; Lee AJ; Vissers PAJ; Cardwell CR
    Br J Cancer; 2020 Jul; 123(2):307-315. PubMed ID: 32367073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between acid-suppressive drug use and atopic dermatitis in patients with upper gastrointestinal diseases: A population-based retrospective cohort study.
    Lin HC; Chen YY; Lin HL; Uang YS; Ho Y; Wang LH
    J Clin Pharm Ther; 2021 Jun; 46(3):786-793. PubMed ID: 33403692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.
    Lam JR; Schneider JL; Quesenberry CP; Corley DA
    Gastroenterology; 2017 Mar; 152(4):821-829.e1. PubMed ID: 27890768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
    Hwang IC; Chang J; Park SM
    Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of proton pump inhibitors for the risk of gastric cancer.
    Gao H; Li L; Geng K; Teng C; Chen Y; Chu F; Zhao Y
    Medicine (Baltimore); 2022 Dec; 101(49):e32228. PubMed ID: 36626449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
    Tamim H; Duranceau A; Chen LQ; Lelorier J
    Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of Concomitant Metformin and Proton Pump Inhibitor Use: A Population Retrospective Cohort Study.
    Chen CB; Lin M; Eurich DT; Johnson JA
    Clin Ther; 2016 Jun; 38(6):1392-1400. PubMed ID: 27061884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N; Yan Y; Su S; Ge Q; Zhai S
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
    Lam JR; Schneider JL; Zhao W; Corley DA
    JAMA; 2013 Dec; 310(22):2435-42. PubMed ID: 24327038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.
    Brusselaers N; Lagergren J; Engstrand L
    Cancer Epidemiol; 2019 Oct; 62():101585. PubMed ID: 31445426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
    Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
    Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
    Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
    Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
    Corley DA; Kubo A; Zhao W; Quesenberry C
    Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers.
    Fan HP; Zhou Y; Chen ML; Qiu KH; Feng X; Zhou C; Zhu ML; Huang RZ; Hu TY
    Pharmacotherapy; 2024 Jul; 44(7):539-548. PubMed ID: 38899757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
    Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
    JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.